Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients
Anti-tumour necrosis factor (TNF) agents have demonstrated efficacy in inflammatory bowel disease (IBD). Cutaneous reactions such as new onset psoriasis or psoriasiform-like reactions are among the most common adverse reactions. We retrospectively identified cases of anti-TNF-induced psoriasis or psoriasiform manifestations in IBD patients at a tertiary centre in Australia. A total of 10 (six females) of 270 (3.7%) IBD patients treated with anti-TNF therapy developed drug-induced psoriatic or...[Show more]
|Collections||ANU Research Publications|
|Source:||Internal Medicine Journal|
|01_Peer_Paradoxical_psoriasiform_2017.pdf||738.96 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.